Ambrosia Bio Presents Preclinical Data on AMB-702 GLP-1 RA
07 Jun 2026 //
BIOSPACE
Ambrosia Biosciences Presents Late-Breaking Poster at 86th ADA
21 Apr 2026 //
FIRSTWORD PHARMA
Ambrosia Bio Closes $100M Series B for Cardiometabolic Pipeline
31 Mar 2026 //
PR NEWSWIRE

Market Place
Sourcing Support